CONNECT WITH US:
Jun 28, 2021 15:00 JST
Avance Clinical Appoints Asia Biotech Specialist to Support APAC Growth
ADELAIDE, AUS, Jun 28, 2021 - (ACN Newswire) - Avance Clinical, the leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient, announced the appointment of Andy Hu as Business Development Manager APAC, to support increasing biotech clinical trial demand from the region.
Formerly with Informa Pharma Intelligence, the international biopharma data company, Andy will head up the APAC business development program for Avance Clinical.
Andy says the main drivers for Asian biotechs looking to Australia are speed, data quality and access to international regulatory authorities.
"They select Avance Clinical in Australia because its CRO data is accepted by the FDA, and it gives them a rapid pathway for international licensing, investment and ultimately drug approvals," he said.
"I wanted to work with Avance Clinical because it's a mid-sized CRO that offers deep therapeutic experience, expedited timelines, and exceptional support to APAC biotech clients."
Avance Clinical has grown significantly over the past two years with an increasing number of clients coming from APAC to conduct their trials in Australia.
Chief Strategy Officer Ben Edwards said the appointment of Andy Hu will further support growth and strengthen relationships with clients in the region.
"Andy is multilingual, being fluent in English, Mandarin and Korean, and has completed both a Bachelor of Korean Language and Culture as well as a Master of Translation and Interpreting. He will be responsible for developing business across the APAC region to better serve our clients operating in the region," he said.
The Avance Clinical team is attending BIO Digital 2021 virtually and is available on the BIO One-on-One Partnering(TM) platform to discuss the benefits of conducting trials in Australia.
Avance Clinical has recently won the BDO Excellence in Business Award 2021 for rapid managed growth and attracting and nurturing experienced staff in a competitive global environment.
The mid-sized CRO has a reputation for going beyond the industry time and support for Sponsors, and for providing staff the training and resources needed to deliver excellence in clinical research management.
About Avance Clinical
Avance Clinical is the largest specialist Australian CRO delivering quality clinical trials in Australia and New Zealand for international biotechs. Avance Clinical has been delivering CRO services in the region for the past 24 years. Our clients are international biotechs in their early phases of drug development that need fast, agile, and adaptive solution-oriented clinical research services. Avance Clinical delivers customised solutions designed around specific client needs rather than a one size fits all approach. As a company we have focussed on state-of-the-art technology and systems across all functional areas to provide our clients with the most effective processes. Medidata, Oracle, and Medrio are just some of our technology partners. The collective pool of knowledge and experience at Avance Clinical continually grows through the careful selection of candidates who demonstrate passion and expertise in their chosen field. Visit
for more information.
Excellence in Business Award 2021
Frost & Sullivan Asia-Pacific CRO Market Leadership Award 2020
Source: Avance Clinical
Sectors: BioTech, Healthcare & Pharm, Clinical Trials
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
TANAKA to Provide Pure Gold, Pure Silver, and Pure Bronze Medals for the Tokyo Marathon 2024
Feb 21, 2024 04:00 JST
Fujitsu collaborates with QuTech in development of new technology for freezing electronics to control diamond spin qubits
Feb 20, 2024 21:28 JST
NTT DOCOMO and SK Telecom Release White Paper on Base Station Equipment Utilizing Virtualization Technology
Feb 20, 2024 15:32 JST
NEC Develops AI Technology for Robotics Capable of Autonomous and Advanced Handling of Disorderly Placed Items
Feb 20, 2024 12:03 JST
JCB and The Bicester Collection expand their partnership to offer more luxury shopping opportunities for Asian travellers
Feb 20, 2024 12:00 JST
National High School in the Philippines Built with the Support of Mitsubishi Motors Holds Opening Ceremony
Feb 20, 2024 11:15 JST
Eisai Selected for 'Human Capital Leaders 2023' and 'Human Capital Management Gold Quality', Recognized as Company Committed to Excellent Management and Disclosure of Human Capital Initiatives
Feb 20, 2024 09:35 JST
TOYOTA GAZOO Racing Finishes Strongly on Swedish Snow
Feb 19, 2024 19:26 JST
MC to Subscribe Shares in TVS Vehicle Mobility Solution in India
Feb 19, 2024 17:42 JST
NEC Enhances Value Added Network Solution Suite to Boost Enterprise Digital Innovation
Feb 19, 2024 16:05 JST
Fujitsu develops technology to speed up quantum circuit computation in quantum simulator by 200 times
Feb 19, 2024 10:26 JST
MHI Recognized by CDP as Being at the Leadership Level for Climate Change Earning A- score
Feb 19, 2024 10:08 JST
MAZDA INNOVATION SPACE TOKYO Opens
Feb 16, 2024 17:29 JST
NEC develops RAN autonomous optimization technology that dynamically controls 5G networks based on user terminal status
Feb 16, 2024 11:42 JST
Eisai: Metoject Subcutaneous Injection Pen (Methotrexate) Pen-Type Autoinjector Approved in Japan
Feb 16, 2024 09:31 JST
PoC Launched to Test Smart-charging Service Using EV Connected Technologies
Feb 15, 2024 16:50 JST
Hitachi Energy and TransnetBW make German grid fit for future
Feb 15, 2024 11:22 JST
JCB Cards are now accepted at Maybank merchant terminals in Singapore
Feb 15, 2024 11:00 JST
Arsaga Partners, Tokyu Land, NTT and DOCOMO to Explore Collaboration for R&D to Create Services with IOWN
Feb 14, 2024 15:40 JST
TMC Announces Personnel Changes in Senior Management
Feb 14, 2024 13:11 JST
More Latest Release >>
Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner
January 12 2024 16:00 JST
Avance Clinical Invited to Brief 45 Korean Biotechs on Their GlobalReady Drug Development Pathway from Korea and Australia to the US
October 19 2023 09:00 JST
Avance Clinical at ASCO & BIO 2023: Early Phase Oncology Trials Increasingly Elaborate and Demand More Patients
May 30 2023 10:00 JST
Avance Clinical Joins Global Health Summit Campaign for Faster Access to Life-Changing and Life-Saving Therapies
May 25 2023 09:00 JST
Avance Clinical CEO Joins Global BioPharma Panel for Evolution Europe Summit 2023
April 18 2023 11:00 JST
Avance Clinical Celebrates GlobalReady Success as 40 Biotechs Join Program
January 11 2023 15:00 JST
Avance Clinical Wins International Health Award for Biotech CRO Services
September 28 2022 16:00 JST
Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs
September 06 2022 13:00 JST
Avance Clinical Sponsors Biotech Company of the Year Awards at Informa Pharma Intelligence Awards 2022
August 29 2022 18:00 JST
Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 - Best Contract Research Organization in APAC
April 19 2022 10:00 JST
More Press release >>